Aptorum Group Limited Reports 2022 Fiscal Year End Financial

Regulatory News:


Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, today... | April 28, 2023

Related Keywords

Jingdong , Guangdong , China , Singapore , United States , Canada , Darren Lui , Aptorum Group Or We , Daptorum Group , Aptorum Group Cayman , Singapore Agency For Science , Nasdaq , Holding Group , Aptorum Group Form , Aptorum Group Limited Nasdaq , Drug Administration , Yu Group , Regulatory News , Group Limited , Euronext Paris , Chief Executive Officer , Executive Director , Methicillin Resistant Staphylococcus , Pipeline Update , Methicillin Resistant Staphylococcus Aureus , Acute Bacterial Skin , Skin Structure Infections , Ordinary Shares , Ordinary Share , Aptorum Group Cayman Limited , Classb Ordinary Shares , Term Sheet , Aptorum Group Limited , Securities Litigation Reform Act , French Autorit , Des March , Regulations Delegated , Years Ended December , Aptorum Group Limited Stock Exchange , News , Information , Press Release , Egulatory , Group , Imited , Linical , Stage , Iopharmaceutical , Company , Edicated , O , Meeting , Unmet , Medical , Needs , N , Autoimmune , Diseases , End , Nfectious Apm Kyg6096m1226 ,